Jazz Pharmaceuticals Non-GAAP EPS of $6.61 Beats by $1.11, Revenue of $1.05B Beats by $10M

Seeking Alpha58minutes ago

GUIDANCE: (JAZZ) JAZZ PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $19.50 - $20.60

MT Newswires05:13

Earnings Flash (JAZZ) JAZZ PHARMACEUTICALS Posts Q3 Revenue $1.06B

MT Newswires05:12

Express News | Jazz Pharmaceuticals Q3 Net Income USD 215.055 Million

Breakings05:05

Express News | Jazz Pharmaceuticals Q3 Adjusted Net Income USD 416.924 Million Vs. IBES Estimate USD 368.7 Million

Breakings05:05

Jazz Pharmaceuticals 3Q Adj EPS $6.61 >JAZZ

Dow Jones05:05